“Over a billion people, one in every six people living on this planet, suffer from one or more neglected tropical diseases, or NTDs,” a VOA editorial states, noting, “These usually treatable and preventable diseases include schistosomiasis; elephantiasis; trachoma; Chagas disease; river blindness; leprosy; kala-azar, dengue, black fever and other forms of leishmaniasis; and the three most common infections — the soil-transmitted parasites hookworm, roundworm and whipworm.”
Access to Health Services
“As Washington prepares for a major international AIDS conference this summer, developments on the drug front are once again elevating the subject of the continuing epidemic in the public eye,” CQ HealthBeat reports. The article mentions an FDA panel’s recent recommendation for the approval of Truvada for pre-exposure prophylaxis (PrEP) to prevent HIV among healthy people at risk of contracting the virus and a bill (S 1138) introduced last week by Sen. Bernie Sanders (I-Vt.) aimed at reducing the cost of antiretroviral drugs (ARVs). The bill, which is focused on the cost of ARVs in the U.S., would “create a $3 billion ‘prize fund,’ through which [pharmaceutical] firms that bring a new HIV or AIDS medicine to market would get awards” in exchange for relinquishing patent rights to the drug, according to CQ (Norman, 5/18).
“Every year, millions of people die from preventable and treatable diseases, especially in poor countries,” World Bank Chief Economist Joseph Stiglitz, a Nobel laureate, writes in this BusinessDay opinion piece. “In many cases, life-saving medicines can be cheaply mass-produced, but are sold at prices that block access to those who need them,” and “many die simply because there are no cures or vaccines, because so little of the world’s valuable research talent and limited resources is devoted to addressing the diseases of the poor,” he continues, arguing, “This state of affairs represents a failure of economics and law that urgently needs to be corrected.” Stiglitz continues, “The good news is that there are now opportunities for change, most promisingly through an international effort headed by the World Health Organization that would begin to fix the broken intellectual-property regime that is holding back the development and availability of cheap drugs.”
“As representatives of the World Health Organization Member States arrive in Geneva this week for the 65th World Health Assembly, I feel a cautious optimism about the future, and the future health of Africa,” Joy Phumaphi, co-chair of the Aspen Global Leaders Council for Reproductive Health, writes in this post in the Huffington Post Blog. “With two female heads of state in Africa – Ellen Johnson Sirleaf in Liberia and Joyce Banda in Malawi – women’s health and gender equality are no longer marginalized, they have become central to a nation’s potential for development and prosperity,” she continues, adding the two “share a vision and passionate resolve to improve the lives of women in Africa — and like me they are founding members of the Aspen Institute’s Global Leaders Council for Reproductive Health.”
Loss Of U.S. Funding For UNFPA 'Would Be Devastating' To Family Planning Services In Developing Countries
“By voting to ban any U.S. contribution to UNFPA” in the FY 2013 State and Foreign Operations appropriations bill, the House Appropriations Committee on Thursday “made a judgment call that saving the lives of women and girls around the world is simply not a U.S. priority,” Valerie DeFillipo, president of Friends of UNFPA, writes in a Huffington Post “Global Motherhood” opinion piece. She notes that “[c]ommittee members voted against amendments that would permit funding to UNFPA for preventing and treating obstetric fistula, ending female genital mutilation, and providing family planning services and contraceptive supplies in nine sub-Saharan African countries with high rates of poverty and maternal mortality where USAID does not provide family planning assistance.”
More Research Needed Into How Transgender Persons In Asia, Pacific Affected By HIV, Stigma, Report Says
A report released Thursday in Bangkok by the United Nations Development Programme (UNDP) and the Asia Pacific Transgender Network (APTN) says more research needs to be conducted to determine the extent to which transgender persons in Asia and the Pacific are affected by HIV, are socially ostracized, and lack fundamental rights, including access to basic health care, a UNDP press release reports. The report, released to mark the International Day Against Homophobia and Transphobia, is “a comprehensive review of material gathered from across the region over the past 12 years” and “emphasizes that inclusive research, designed and implemented in partnership with the transgender community, is critical to enable governments, community-based organizations and supporting organizations to enhance HIV and sexual health care services specific to the needs of transgender people, and foster action by governments to adopt more socially equitable policies and practices to protect their rights,” according to the press release (5/17).
AIDS activists in Uganda are worried about a proposed reduction in the country’s health budget, as Parliament begins “a months-long budgeting process for the … next fiscal year,” VOA News reports. “AIDS activists have expressed concern that Uganda’s proposed budget for the next fiscal year includes a six percent cut in health funding to $307.5 million,” which “is less than 10 percent of the country’s overall budget,” the news service writes. Joshua Wamboga of The AIDS Support Organization said a lack of financial commitment from the government could undermine efforts to fight HIV/AIDS in the country, VOA notes, adding, “Government officials said the cut to the health budget reflects construction projects in that sector that have been completed and no longer require funding.” According to VOA, “The budget is months away from being finalized and activists hope there is still time to increase funds” (Green, 5/15).
Newly released “estimates of maternal mortality from the United Nations’ Maternal Mortality Estimation Inter-Agency Group (MMEIG) are good news — but not good enough,” Peter Byass, professor of global health at Umea University in Sweden and director of the Umea Centre for Global Health Research, writes in this post in the PLoS “Speaking of Medicine” blog. He briefly discusses the pros and cons of using “estimates” for maternal mortality data, and he concludes, “There is a risk involved for every woman who gets pregnant. But the global community has the knowledge and resources to manage those risks and minimize adverse consequences. Why can’t we stop mothers dying?” (5/16).
Maternal Deaths Drop By Nearly Half Worldwide Over 20 Years; Greater Progress Still Needed, U.N. Reports
“The number of women dying of pregnancy- and childbirth-related complications has almost halved in 20 years, according to new estimates released [on Wednesday] by the United Nations, which stressed that greater progress is still needed in significantly reducing maternal deaths,” the U.N. News Centre reports (5/16). “The report, ‘Trends in Maternal Mortality: 1990 to 2010,’ shows that from 1990 to 2010, the annual number of maternal deaths dropped from more than 543,000 to 287,000 — a decline of 47 percent,” a UNFPA press release states (5/16). However, “[w]hile substantial progress has been achieved in almost all regions, many countries, particularly in sub-Saharan Africa, will fail to reach the Millennium Development Goal (MDG) target of reducing maternal death by 75 percent through 2015,” Inter Press Service writes (Deen, 5/16). “Countries in Eastern Asia have made [the] most progress on improving the health of expectant and new mothers, said the report,” Agence France-Presse adds (5/16).
In her blog, “The Garrett Update,” Laurie Garrett, senior fellow for global health at the Council on Foreign Relations (CFR), provides a detailed overview of the key findings from the council’s Policy Innovation Memorandum No. 21, a six-point policy recommendation for the G8/20 that she authored, titled “Ensuring the Safety and Integrity of the World’s Drug, Vaccine, and Medicines Supply.” She writes, “Overall we find that very little data regarding the scale and impact of the unsafe drugs, medicines, and vaccines problem is reliable,” adding, “Caution is advised when using any commonly cited data regarding medicines safety or crime” (May 2012).